Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 23203116)


Impact of detergent on biophysical properties and immune response of the IpaDB fusion protein, a candidate subunit vaccine against Shigella species.

Chen X, Choudhari SP, Martinez-Becerra FJ, Kim JH, Dickenson NE, Toth RT 4th, Joshi SB, Greenwood JC 2nd, Clements JD, Picking WD, Middaugh CR, Picking WL.

Infect Immun. 2015 Jan;83(1):292-9. doi: 10.1128/IAI.02457-14. Epub 2014 Nov 3.


Influence of oligomerization state on the structural properties of invasion plasmid antigen B from Shigella flexneri in the presence and absence of phospholipid membranes.

Adam PR, Dickenson NE, Greenwood JC 2nd, Picking WL, Picking WD.

Proteins. 2014 Nov;82(11):3013-22. doi: 10.1002/prot.24662. Epub 2014 Aug 21.


NMR model of PrgI-SipD interaction and its implications in the needle-tip assembly of the Salmonella type III secretion system.

Rathinavelan T, Lara-Tejero M, Lefebre M, Chatterjee S, McShan AC, Guo DC, Tang C, Galan JE, De Guzman RN.

J Mol Biol. 2014 Aug 12;426(16):2958-69. doi: 10.1016/j.jmb.2014.06.009. Epub 2014 Jun 18.


B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection.

Nothelfer K, Arena ET, Pinaud L, Neunlist M, Mozeleski B, Belotserkovsky I, Parsot C, Dinadayala P, Burger-Kentischer A, Raqib R, Sansonetti PJ, Phalipon A.

J Exp Med. 2014 Jun 2;211(6):1215-29. doi: 10.1084/jem.20130914. Epub 2014 May 26.


Single amino acid substitutions on the needle tip protein IpaD increased Shigella virulence.

Meghraoui A, Schiavolin L, Allaoui A.

Microbes Infect. 2014 Jul;16(7):532-9. doi: 10.1016/j.micinf.2014.03.010. Epub 2014 Apr 12.


IcsA is a Shigella flexneri adhesin regulated by the type III secretion system and required for pathogenesis.

Brotcke Zumsteg A, Goosmann C, Brinkmann V, Morona R, Zychlinsky A.

Cell Host Microbe. 2014 Apr 9;15(4):435-45. doi: 10.1016/j.chom.2014.03.001.


A fluorescent reporter reveals on/off regulation of the Shigella type III secretion apparatus during entry and cell-to-cell spread.

Campbell-Valois FX, Schnupf P, Nigro G, Sachse M, Sansonetti PJ, Parsot C.

Cell Host Microbe. 2014 Feb 12;15(2):177-89. doi: 10.1016/j.chom.2014.01.005.


A substrate-fusion protein is trapped inside the Type III Secretion System channel in Shigella flexneri.

Dohlich K, Zumsteg AB, Goosmann C, Kolbe M.

PLoS Pathog. 2014 Jan;10(1):e1003881. doi: 10.1371/journal.ppat.1003881. Epub 2014 Jan 16.


Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes.

Heine SJ, Diaz-McNair J, Andar AU, Drachenberg CB, van de Verg L, Walker R, Picking WL, Pasetti MF.

J Immunol. 2014 Feb 15;192(4):1630-40. doi: 10.4049/jimmunol.1302743. Epub 2014 Jan 22.


N-terminus of IpaB provides a potential anchor to the Shigella type III secretion system tip complex protein IpaD.

Dickenson NE, Arizmendi O, Patil MK, Toth RT 4th, Middaugh CR, Picking WD, Picking WL.

Biochemistry. 2013 Dec 10;52(49):8790-9. doi: 10.1021/bi400755f. Epub 2013 Nov 20.


Spa13 of Shigella flexneri has a dual role: chaperone escort and export gate-activator switch of the type III secretion system.

Cherradi Y, Hachani A, Allaoui A.

Microbiology. 2014 Jan;160(Pt 1):130-41. doi: 10.1099/mic.0.071712-0. Epub 2013 Oct 14.


The inside story of Shigella invasion of intestinal epithelial cells.

Carayol N, Tran Van Nhieu G.

Cold Spring Harb Perspect Med. 2013 Oct 1;3(10):a016717. doi: 10.1101/cshperspect.a016717. Review.


Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine.

Martinez-Becerra FJ, Chen X, Dickenson NE, Choudhari SP, Harrison K, Clements JD, Picking WD, Van De Verg LL, Walker RI, Picking WL.

Infect Immun. 2013 Dec;81(12):4470-7. doi: 10.1128/IAI.00859-13. Epub 2013 Sep 23.


Measurement of transmembrane peptide interactions in liposomes using Förster resonance energy transfer (FRET).

Khadria A, Senes A.

Methods Mol Biol. 2013;1063:19-36. doi: 10.1007/978-1-62703-583-5_2.


Site-specific labeling of the type 1 ryanodine receptor using biarsenical fluorophores targeted to engineered tetracysteine motifs.

Fessenden JD, Mahalingam M.

PLoS One. 2013 May 28;8(5):e64686. doi: 10.1371/journal.pone.0064686. Print 2013.


Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.

Heine SJ, Diaz-McNair J, Martinez-Becerra FJ, Choudhari SP, Clements JD, Picking WL, Pasetti MF.

Vaccine. 2013 Jun 19;31(28):2919-29. doi: 10.1016/j.vaccine.2013.04.045. Epub 2013 May 2.


Parenteral immunization with IpaB/IpaD protects mice against lethal pulmonary infection by Shigella.

Martinez-Becerra FJ, Scobey M, Harrison K, Choudhari SP, Quick AM, Joshi SB, Middaugh CR, Picking WL.

Vaccine. 2013 May 31;31(24):2667-72. doi: 10.1016/j.vaccine.2013.04.012. Epub 2013 Apr 16.


Structure and biophysics of type III secretion in bacteria.

Chatterjee S, Chaudhury S, McShan AC, Kaur K, De Guzman RN.

Biochemistry. 2013 Apr 16;52(15):2508-17. doi: 10.1021/bi400160a. Epub 2013 Apr 5. Review.


A novel effector secretion mechanism based on proton-motive force-dependent type III secretion apparatus rotation.

Ohgita T, Hayashi N, Hama S, Tsuchiya H, Gotoh N, Kogure K.

FASEB J. 2013 Jul;27(7):2862-72. doi: 10.1096/fj.13-229054. Epub 2013 Mar 20.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk